Sarah Pierce Bregante
Medical · Austin, TXNPI 1124164934
Payments from drug & device makers
Across 213 payments — averaging $15.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$907
- AbbVie$661
- Lilly USA, LLC$304
- Pfizer$261
- AstraZeneca$212
- Abbott$151
- plus $905 from 26 others
What the payments were for
- Food & beverage$3,37699%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 65 | $907 |
| AbbVie | 44 | $661 |
| Lilly USA, LLC | 18 | $304 |
| Pfizer | 14 | $261 |
| AstraZeneca | 12 | $212 |
| Abbott | 8 | $151 |
| Boehringer Ingelheim | 7 | $127 |
| GSK | 6 | $92 |
| Amgen(2 entities) | 5 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $55 |
| Bayer | 3 | $53 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Amarin Pharma, Inc. | 2 | $32 |
| Viiv Healthcare Company | 1 | $31 |
| Exeltis, USA Inc. | 2 | $29 |
| Currax Pharmaceuticals LLC | 1 | $25 |
| Sanofi Pasteur Inc. | 1 | $23 |
| Gilead | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Exact Sciences | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Clarus Therapeutics Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $16 |
| Merck | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
How this compares
$3,401 in reported general payments places this provider in the 75th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $18,368 |
| MounjaroTirzepatide | 13 | $16,207 |
| FarxigaDapagliflozin Propanediol | 22 | $13,897 |
| LivaloPitavastatin Calcium | 11 | $4,053 |
| Levothyroxine Sodium | 244 | $3,362 |
| SynthroidLevothyroxine Sodium | 56 | $3,000 |
| PaxlovidNirmatrelvir/Ritonavir | 32 | $2,858 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $2,793 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 66 | $1,946 |
| Rosuvastatin Calcium | 168 | $1,916 |
| Estradiol | 21 | $1,715 |
| Atorvastatin Calcium | 203 | $1,622 |
| ValacyclovirValacyclovir Hcl | 48 | $1,413 |
| Lisinopril | 144 | $1,397 |
| Losartan Potassium | 107 | $1,120 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $907 | $18,36818 claims |
| AstraZenecaFarxiga, Symbicort | $212 | $16,69035 claims |
| Lilly USA, LLCMounjaro | $304 | $16,20713 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $14 | $4,05311 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $20 | $3,362244 claims |
| AbbVieSynthroid | $661 | $3,00056 claims |
| PfizerPaxlovid | $261 | $2,85832 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,490 medical providers in Texas.
Other medical in Austin
- Isabell BacotAustin$65K
- Lindsay ReckAustin$18K
- Amela PettyAustin$16K
- Jeri BelyeaAustin$14K
- Mikel ZamoraAustin$13K
- Theresa ManriquezAustin$13K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.